Overview

Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers

Status:
Completed
Trial end date:
2021-05-04
Target enrollment:
Participant gender:
Summary
To evaluate the interaction between two investigational products by comparing and analyzing pharmacokinetic interactions and safety in steady state after multiple oral administration of ATB-1011 or ATB-1012 alone or in combination in healthy adult volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
Autotelicbio
Treatments:
Dapagliflozin
Olmesartan